AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oramed Pharmaceuticals Inc.

Director's Dealing Apr 3, 2024

6965_rns_2024-04-03_6f8fb71e-561f-4191-8833-e5cae57661d9.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

SEC Form 3

FORM 3 UNITED STATES SECURITIES AND EXCHANGE

COMMISSION Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number: 3235- 0104

Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*
Reznick Yehuda
2. Date of Event
3. Issuer Name and Ticker or Trading Symbol
Requiring Statement
ORAMED PHARMACEUTICALS INC.
[ ORMP ]
(Month/Day/Year)
04/01/2024
(Last)
(First)
(Middle)
1185 AVENUE OF THE
4. Relationship of Reporting Person(s) to
Issuer
(Check all applicable)
5. If Amendment, Date of Original
Filed (Month/Day/Year)
AMERICAS, THIRD FLOOR X
Director
10% Owner
Other (specify
6. Individual or Joint/Group Filing
(Street)
NEW
YORK
NY 10036 Officer (give
title below)
below) (Check Applicable Line)
X
Person
Reporting Person
Form filed by One Reporting
Form filed by More than One
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities
3. Ownership
Beneficially Owned (Instr.
Form: Direct
(D) or Indirect
(I) (Instr. 5)
4. Nature of Indirect Beneficial
Ownership (Instr. 5)
4)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and
Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities
Underlying Derivative Security
(Instr. 4)
4.
Conversion
or Exercise
Price of
5.
Ownership
Form:
Direct (D)
6. Nature of
Indirect Beneficial
Ownership (Instr.
5)

Explanation of Responses:

No securities are beneficially owned.

/s/ Yehuda Reznick 04/02/2024

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Talk to a Data Expert

Have a question? We'll get back to you promptly.